2Nagase H, Woessner JF, Jr. Matrix metalloproteinases. J. Bio.Chem. 1999, 274:21491-21494.
3Park HI, Gerkema FE, Liu D, et al. Identification and characterization of human endometas (Matrix metaUoproteinase-26) from endometrial tumor. J. Biol. Chem. 2000; 275 : 20540 - 20544.
4Lennarz WJ, Strittmatter WJ. Cellular function of metalloendoproteinases. Biochim Biophys Acta, 1991 ; 1071 : 149 - 158.
5Baker AH, Ahonen M, Kahari VM. Potential applications of tissue inhibitor of metalloproteinase(TIMP ) overexpression for cancer gene therapy. Adv Exp Med Biol, 2000 ; 465:469 - 483.
6Janowska-Wieczorek A, Matsuzaki A, Marguez L, et al. The hematopoietic microenviroment: matrix metalloproteinases in the hematopoietic microenviroment. Hematol, 2000; 4:515-527.
7Ries C, Kolb H, Petrides PE. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood,1994; 83:3638- 3646.
8Ismair MG, Ries C, Lottspeich F, a al. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-α(TNF-α) in NB4 leukemic cell:specific involvement of TNF receptor type 1. Leukemia, 1998; 12:1136- 1143.
9Ries C, Lottspeich F, Dittmarm KH, et al. HL-60 leukemia cell produce an autocatalytically truncated form of matrix metallopro-teinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases. Leukemia, 1996; 10:1520 - 1526.
10Ries C, Loher F, Zang C, et al. Matrix metaUoproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res, 1999; 5:1115 - 1124.
2Del Duca D,Werbowetski T,Del Maestro RF.Spheroid preparation from hanging drops:characterization of a model of brain tumor invasion.J Neurooncol,2004,67:295-303.
3Nakada M,Kita D,Futami K,et al.Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.J Neurosurg,2001,94:464-473.
4Murray GI,Duncan M,Arbuckle E,et al.Matrix metalloproteinases and their inhibitors in gastde cancer.Gut,1998,43:791-797.
5Vescovi AL,Galli R,Reynolds BA.Brain tumour stem cells.Nat Bey Cancer,2006,6:425-436.
6Fang JS,Deng YW,Li MC,et al.Isolation and identification of brain tumor stem cells from human brain neuroeptithelial tumors.Zhong Han Yi Xue Za Zhi,2007,87:298-303.
7Noe V et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. CellSci, 2001, 114:111-118.
8Stallings-Mann M et al. Matrix metalloproteinase-iaduced malignancy in mammary epithelial cells. Cells Tissues Organs, 2007, 185:104-110.
9Ota I et al. Induction of a MT1-MMP and MT2- MMP-dependent basement membrane transmigration program in cancer cells by Snail I. Proc Natl Acad Sci USA, 2009, 106:20318-20323.
10Mori K et al. lnvasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res, 2004, 64: 7464- 7472.
